Cadrenal Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Cadrenal Therapeutics, Inc. (CVKD) reported Basic Shares Outstanding (Weighted Average) of 2.91 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.91M shares, a 48.51% increase year-over-year.
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 2.41M shares, a 30.56% increase year-over-year.
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.12M shares, a 80.80% increase year-over-year.
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 2.04M shares, a 85.15% increase year-over-year.
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.99M shares, a 63.48% increase from fiscal 2024.
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.22M shares, a 35.59% increase from fiscal 2023.
- Cadrenal Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 899.47K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 2 month | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 5 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 8 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 11 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.91M shares 10-Q · filed 2026-08-13 | 2.66M shares 10-Q · filed 2026-08-13 | 2.48M shares derived: average of 3 quarters · filed 2026-08-13 | 2.37M shares derived: average of 4 quarters · filed 2026-08-13 | ||||||||
| 2026-03-31 | 2.41M shares 10-Q · filed 2026-05-07 | 2.27M shares derived: average of 2 quarters · filed 2026-05-07 | 2.19M shares derived: average of 3 quarters · filed 2026-05-07 | 2.13M shares derived: average of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-12-31 | 2.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.08M shares derived: average of 2 quarters · filed 2026-03-31 | 2.04M shares derived: average of 3 quarters · filed 2026-08-13 | 1.99M shares 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | 2.04M shares 10-Q · filed 2025-11-10 | 2.00M shares derived: average of 2 quarters · filed 2026-08-13 | 1.95M shares 10-Q · filed 2025-11-10 | 1.76M shares derived: average of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-06-30 | 1.96M shares 10-Q · filed 2026-08-13 | 1.90M shares 10-Q · filed 2026-08-13 | 1.66M shares derived: average of 3 quarters · filed 2026-08-13 | 1.52M shares derived: average of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-03-31 | 1.84M shares 10-Q · filed 2026-05-07 | 1.51M shares derived: average of 2 quarters · filed 2026-05-07 | 1.37M shares derived: average of 3 quarters · filed 2026-05-07 | 1.30M shares derived: average of 4 quarters · filed 2026-05-07 | ||||||||
| 2024-12-31 | 1.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.14M shares derived: average of 2 quarters · filed 2026-03-31 | 1.12M shares derived: average of 3 quarters · filed 2026-03-31 | 1.22M shares 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | 1.10M shares 10-Q · filed 2025-11-10 | 1.09M shares derived: average of 2 quarters · filed 2025-11-10 | 1.23M shares 10-Q · filed 2025-11-10 | 1.08M shares 10-Q · filed 2024-11-07 | 1.08M shares derived: average of 4 quarters · filed 2025-11-10 | |||||||
| 2024-06-30 | 1.07M shares 10-Q · filed 2025-08-11 | 16.01M shares 10-Q · filed 2024-08-07 | 1.07M shares 10-Q · filed 2025-08-11 | 16.01M shares 10-Q · filed 2024-08-07 | 1.07M shares derived: average of 3 quarters · filed 2025-08-11 | 1.06M shares derived: average of 4 quarters · filed 2025-08-11 | ||||||
| 2024-03-31 | 1.07M shares 10-Q · filed 2025-05-08 | 16.01M shares 10-Q · filed 2024-05-09 | 1.07M shares derived: average of 2 quarters · filed 2025-05-08 | 1.05M shares derived: average of 3 quarters · filed 2025-05-08 | 3.72M shares derived: average of 4 quarters · filed 2025-05-08 | |||||||
| 2023-12-31 | 1.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 1.05M shares derived: average of 2 quarters · filed 2025-03-13 | 4.61M shares derived: average of 3 quarters · filed 2025-03-13 | 899.47K shares 10-K · filed 2025-03-13 | 13.49M shares 10-K · filed 2024-03-11 | |||||||
| 2023-09-30 | 1.03M shares 10-Q · filed 2024-11-07 | 15.40M shares 10-Q · filed 2023-11-09 | 6.37M shares derived: average of 2 quarters · filed 2024-11-07 | 842.72K shares 10-Q · filed 2024-11-07 | 12.64M shares 10-Q · filed 2023-11-09 | |||||||
| 2023-06-30 | 11.72M shares 10-Q · filed 2024-08-07 | 11.25M shares 10-Q · filed 2024-08-07 | ||||||||||
| 2023-03-31 | 10.77M shares 10-Q · filed 2024-05-09 | |||||||||||
| 2022-12-31 | 7.89M shares 10-K · filed 2024-03-11 | |||||||||||
| 2022-09-30 | 8.04M shares 10-Q · filed 2023-11-09 | 7.88M shares derived: average of 2 quarters · filed 2023-11-09 | 7.78M shares 10-Q · filed 2023-11-09 | |||||||||
| 2022-06-30 | 7.72M shares 10-Q · filed 2023-08-10 | 7.63M shares 10-Q · filed 2023-08-10 | ||||||||||
| 2022-03-31 | 7.50M shares 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |